Table 3.
Multivariate analysis of WHOCS-1 and WHOCS-2 variability.
| Multivariate | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| WHOCS-1 | WHOCS-2 | ||||||||
| Estimate | SE | P | P′ | Estimate | SE | P | P′ | ||
| (Intercept) | 1.962 | 0.156 | <0.001 | <0.001 | (Intercept) | 2.597 | 0.141 | <0.001 | <0.001 |
| Dyslipidemia | 0.579 | 0.137 | <0.001 | <0.001 | Dyslipidemia | 0.551 | 0.124 | <0.001 | <0.001 |
| TMPRSS2 rs75603675 C/C + C/A versus A/A | 0.591 | 0.138 | <0.001 | <0.001 | TMPRSS2 rs75603675 C/C + C/A versus A/A | 0.405 | 0.125 | 0.001 | 0.005 |
| CCI | 0.101 | 0.030 | 0.001 | 0.003 | CCI | 0.120 | 0.027 | <0.001 | <0.001 |
| Sex | −0.326 | 0.122 | 0.008 | 0.032 | Sex | -0.415 | 0.111 | <0.001 | 0.001 |
WHOCS-1, modified World Health Organization COVID-19 severity scale at first hospital examination; WHOCS-2, highest score on the modified World Health Organization COVID-19 severity scale; CCI, Charlson Comorbidity Index; SE, standard error; P, nominal significance; P’, significance after Bonferroni correction for multiple comparisons.